Capillary plasma separation microsampling devices: a solution for dried blood spot limitations in clinical testing
Dried blood spot (DBS) testing has gained significant popularity in the field of bioanalysis, particularly in therapeutic drug monitoring applications. A PubMed search using the term "dried blood spot testing", restricted to 2002–2012, produced 99 results, whereas a search for 2013–2022 resulted in 1094 results.
These devices represent a step forward for the more widespread application of capillary microsampling in laboratory medicine, facilitating the prediction of plasma/serum concentrations after the collection of capillary blood.
Share this article:
Health ID is reshaping blood collection, making the experience simpler and accessible for all.
Thank you for contacting us. We will get back to you as soon as possible.
All rights reserved | health id